biomarker panel development

Arterez, Inc. is a Michigan biosciences group focused on the discovery and development of therapeutics and diagnostics against chronic vascular diseases, beginning with cardiovascular disease (CVD), by targeting upstream multifactorial root causes. Its platform involves proprietary combo therapies and multi-marker diagnostics addressing disruption of the endothelial glycocalyx.

Read more

diagnostics developmentpreclinical studiestherapeutics discovery and development